HEPATIC FIBROSIS
Clinical trials for HEPATIC FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC FIBROSIS trials appear
Sign up with your email to follow new studies for HEPATIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New liver drug safety trial begins for hepatitis b scarring
Disease control Recruiting nowThis study tests a drug called hydronidone in 300 adults with liver scarring (fibrosis or cirrhosis) from chronic hepatitis B. Participants take the drug three times daily for 28 days to see if it is safe. The main goal is to track any side effects.
Matched conditions: HEPATIC FIBROSIS
Phase: PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a common vitamin stop liver scarring? new trial aims to find out
Disease control Recruiting nowThis phase 2 trial tests whether nicotinamide (a form of vitamin B3) can stop or reverse liver fibrosis in people with non-alcoholic fatty liver disease and obesity. Thirty adults will take either nicotinamide or a placebo daily for one year. Researchers will measure liver stiffn…
Matched conditions: HEPATIC FIBROSIS
Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Simple blood test could spot silent liver damage early
Knowledge-focused Recruiting nowThis study is testing a two-step screening method to find advanced liver fibrosis in people who don't yet have symptoms. First, a routine blood test calculates a score called FIB-4. If that score is high, patients get a more specialized non-invasive test. The goal is to see how w…
Matched conditions: HEPATIC FIBROSIS
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC